These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15342205)

  • 1. Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patients.
    Giorelli M; Livrea P; Trojano M
    J Neuroimmunol; 2004 Oct; 155(1-2):143-9. PubMed ID: 15342205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered beta2-adrenergic regulation of T cell activity after allergen challenge in asthma.
    Heijink IH; van den Berge M; Vellenga E; de Monchy JG; Postma DS; Kauffman HF
    Clin Exp Allergy; 2004 Sep; 34(9):1356-63. PubMed ID: 15347367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1.
    Zoukos Y; Leonard JP; Thomaides T; Thompson AJ; Cuzner ML
    Ann Neurol; 1992 Jun; 31(6):657-62. PubMed ID: 1325138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenoreceptor-coupled signal-transduction mechanisms mediating lymphocyte apoptosis induced by endogenous catecholamines.
    Jiang JL; Peng YP; Qiu YH; Wang JJ
    J Neuroimmunol; 2009 Aug; 213(1-2):100-11. PubMed ID: 19559489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncanonical cAMP pathway and p38 MAPK mediate beta2-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts.
    Yin F; Wang YY; Du JH; Li C; Lu ZZ; Han C; Zhang YY
    J Mol Cell Cardiol; 2006 Mar; 40(3):384-93. PubMed ID: 16466739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Agonist enhances type 2 T-cell survival and accumulation.
    Loza MJ; Peters SP; Foster S; Khan IU; Penn RB
    J Allergy Clin Immunol; 2007 Jan; 119(1):235-44. PubMed ID: 17208607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue inhibitor of metalloproteinase 1 expression and secretion are induced by beta-adrenergic stimulation in 3T3-L1 adipocytes.
    Kralisch S; Lossner U; Bluher M; Paschke R; Stumvoll M; Fasshauer M
    J Endocrinol; 2006 Jun; 189(3):665-70. PubMed ID: 16731796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-stimulated reactive oxygen species formation regulates beta2-adrenergic receptor signal transduction.
    Moniri NH; Daaka Y
    Biochem Pharmacol; 2007 Jun; 74(1):64-73. PubMed ID: 17451656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.
    Ysrraelit MC; Gaitán MI; Lopez AS; Correale J
    Neurology; 2008 Dec; 71(24):1948-54. PubMed ID: 19064876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Catecholamine levels in plasma and beta2-adrenoreceptor-dependent synthesis of cAMP in lymphocytes of patients with primary pulmonary hypertension].
    Irodova NL; Krasnikova TL; Masenko VP; Kochetov AG; Lazutkina VK; Chazova IE
    Ter Arkh; 2002; 74(6):55-9. PubMed ID: 12136487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of beta2-adrenergic receptor dephosphorylation: Comparison with the rate of resensitization.
    Tran TM; Friedman J; Baameur F; Knoll BJ; Moore RH; Clark RB
    Mol Pharmacol; 2007 Jan; 71(1):47-60. PubMed ID: 17012621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling.
    Nikolaev VO; Bünemann M; Schmitteckert E; Lohse MJ; Engelhardt S
    Circ Res; 2006 Nov; 99(10):1084-91. PubMed ID: 17038640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
    Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
    Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis.
    Lombardi MS; Kavelaars A; Schedlowski M; Bijlsma JW; Okihara KL; Van de Pol M; Ochsmann S; Pawlak C; Schmidt RE; Heijnen CJ
    FASEB J; 1999 Apr; 13(6):715-25. PubMed ID: 10094932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some alterations of the leucocyte beta2-adrenoceptor/cAMP-system in patients with seasonal allergic rhinoconjunctivitis are related to disease activity.
    Haen E; Bleise U; Przybilla B
    Clin Exp Allergy; 1997 Jul; 27(7):787-95. PubMed ID: 9249271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.
    Azoulay D; Mausner-Fainberg K; Urshansky N; Fahoum F; Karni A
    J Neuroimmunol; 2009 Jun; 211(1-2):114-9. PubMed ID: 19419774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin disrupts beta-adrenergic signalling to protein kinase A in adipocytes.
    Zhang J; Hupfeld CJ; Taylor SS; Olefsky JM; Tsien RY
    Nature; 2005 Sep; 437(7058):569-73. PubMed ID: 16177793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenaline reduces the ATP-stimulated phosphorylation of p38 MAP kinase via beta-adrenergic receptors-cAMP-protein kinase A-dependent mechanism in cultured rat spinal microglia.
    Morioka N; Tanabe H; Inoue A; Dohi T; Nakata Y
    Neurochem Int; 2009 Sep; 55(4):226-34. PubMed ID: 19524113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
    Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.